Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDA | P32320 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | PNP | P00491 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 4/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.30 |
| ▸ | THPO | P40225 | 2/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.30 |
| ▸ | MTOR | P42345 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | HBB | P68871 | 1/20 | 0.30 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
| ▸ | EIF4E | P06730 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1115489 | 0.84 | CDA (0.33) | CDAMAPTFDPSPNP | |
| SCHEMBL2472521 | 0.79 | CDA (0.35) | CDAMAPTALDH1A1PNPLMNA | |
| SCHEMBL1115485 | 0.76 | ADORA1 (0.39) | ADORA1 | |
| SCHEMBL2819497 | 0.73 | ADORA1 (0.39) | ADORA1 | |
| SCHEMBL29690112 | 0.72 | MMP12 (0.41) | RAB9ALGALS1LGALS3 | |
| Phosphoric Acid SCHEMBL30522657 | 0.71 | PYGL (0.45) | CDAMAPTLMNASMN1; SMN2PMP22 | |
| SCHEMBL27566400 | 0.68 | LGALS1 (0.38) | LGALS1LGALS3 | |
| SCHEMBL31572016 | 0.67 | MMP12 (0.39) | LGALS1LGALS3 | |
| SCHEMBL11284980 | 0.65 | PYGL (0.50) | MAPTLMNASMN1; SMN2PMP22GMNN | |
| SCHEMBL6489385 | 0.65 | PYGL (0.50) | MAPTLMNASMN1; SMN2PMP22GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346910-A1 | METHODS AND COMPOSITIONS TO PREVENT MICROBIAL INFECTION | COMMENSE BIO INC (US) | 2025-11-13 | — | — | US | claimed |
| US-12163135-B2 | Methods and compositions to prevent microbial infection | BioPlx, Inc. (US) | 2024-12-10 | — | — | US | claimed |
| US-20230390297-A1 | USE OF NUCLEOTIDE SYNTHESIS INHIBITORS FOR TARGETED THERAPY IN MLL3/4 COMPASS MUTANT CANCER | NORTHWESTERN UNIVERSITY | 2023-12-07 | — | — | US | claimed |
| EP-4158010-A1 | METHODS FOR STABLE GENOMIC INTEGRATION IN RECOMBINANT MICROORGANISMS | BioPlx, Inc. (US) | 2023-04-05 | — | — | EP | claimed |
| US-20220288135-A1 | LIVE BIOTHERAPEUTIC COMPOSITIONS AND METHODS | BioPlx, Inc. (US) | 2022-09-15 | — | — | US | claimed |
| EP-4017527-A1 | COMBINATION THERAPY OF A T CELL THERAPY AND AN ENHANCER OF ZESTE HOMOLOG 2 (EZH2) INHIBITOR AND RELATED METHODS | Juno Therapeutics, Inc. (US) | 2022-06-29 | — | — | EP | claimed |
| CN-114555112-A | Combination therapy of T cell therapy and ZESTE enhancer homolog 2(EZH2) inhibitors and related methods | 朱诺治疗学股份有限公司 | 2022-05-27 | — | — | CN | claimed |
| US-11324787-B2 | Analytical methods and arrays for use in the same | SENZAGEN AB (SE) | 2022-05-10 | — | — | US | claimed |
| US-20220025364-A1 | METHODS FOR STABLE GENOMIC INTEGRATION IN RECOMBINANT MICROORGANISMS | COMMENSE BIO, INC. | 2022-01-27 | — | — | US | claimed |
| EP-3613416-B1 | APPLICATIONS OF SPERMINE AND ITS DERIVATIVE IN PREPARATION OF ANTITUMOR DRUG | GENEHEAL BIOTECHNOLOGY CO LTD (CN) | 2021-12-15 | — | — | EP | claimed |
| US-8158360-B2 | Effects of inhibitors of FGFR3 on gene transcription | NOVARTIS AG (CH) | 2012-04-17 | — | — | US | claimed |
| WO-2009128644-A9 | GENOME-SCALE BUTANOL-PRODUCING MICROORGANISM METABOLIC NETWORK MODEL AND METHODS USING THE SAME FOR ANALYSIS OF METABOLIC CHARACTERISTICS OF BUTANOL-PRODUCING MICROORGANISMS AND FOR SCREENING DELETION TARGETS | 한국과학기술원 (KR) | 2010-04-15 | — | — | WO | claimed |
| WO-2009128644-A2 | GENOME-SCALE BUTANOL-PRODUCING MICROORGANISM METABOLIC NETWORK MODEL AND METHODS USING THE SAME FOR ANALYSIS OF METABOLIC CHARACTERISTICS OF BUTANOL-PRODUCING MICROORGANISMS AND FOR SCREENING DELETION TARGETS | 한국과학기술원 (KR) | 2009-10-22 | — | — | WO | claimed |
| EP-1668154-B1 | METHODS USEFUL FOR DETECTING AN ALTERATION IN A LOCUS COPY NUMBER | TRISOGEN BIOTECHNOLOGY LTD PAR (IL) | 2008-11-26 | — | — | EP | claimed |
| US-20070004015-A1 | Novel metabolism-associated gene products from ashbya gossypii | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-04 | — | — | US | claimed |
| US-20060040279-A1 | DNA chips used for bioprocess control | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-02-23 | — | — | US | claimed |
| EP-0667781-B1 | PEPTIDE DIAGNOSTICS AND THERAPEUTICS FOR SPONDYLOARTHROPATHIES | OKLAHOMA MED RES FOUND (US) | 2000-03-15 | — | — | EP | claimed |
| US-5719064-A | AUTOIMMUNE DISEASES | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 1998-02-17 | — | — | US | claimed |
| EP-0667781-A1 | PEPTIDE DIAGNOSTICS AND THERAPEUTICS FOR SPONDYLOARTHROPATHIES | BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 1995-08-23 | — | — | EP | claimed |
| WO-1994005303-A1 | PEPTIDE DIAGNOSTICS AND THERAPEUTICS FOR SPONDYLOARTHROPATHIES | BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 1994-03-17 | — | — | WO | claimed |